Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.27
Delayed Data
As of May 22
 -0.02 / -0.87%
Today’s Change
1.85
Today|||52-Week Range
4.97
-14.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$305.1M

Company Description

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.

Contact Information

Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington Massachusetts 02421
P:(781) 274-8200
Investor Relations:
(781) 541-7250

Employees

Shareholders

Other institutional38.04%
Individual stakeholders37.08%
Mutual fund holders11.52%

Top Executives

Chen SchorPresident, Chief Executive Officer & Director
Marc R. SchneebaumChief Financial Officer & Senior Vice President
Vojo VukovicChief Medical Officer & Senior Vice President
Dvorit SamidVice President-Medical Affairs
Sheila WilsonVice President-Clinical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account